Rebeccamycin analog for refractory breast cancer: A randomized phase II trial of dosing schedules

By Burstein Harold   Overmoyer Beth   Gelman Rebecca   Silverman Paula   Savoie Jennifer   Clarke Kathryn   Dumadag Leda   Younger Jerry   Ivy Percy   Winer Eric  

Investigational New Drugs, Vol. 25, Iss. 2, 2007-04 ,pp. : 161-164

Springer Publishing Company

Access to resources Recommend Favorite

A phase III trial of Reopro [abciximab] for the treatment of patients with acute ischaemic stroke (AbESTT-II) has been temporarily suspended

By  

Reactions Weekly, Vol. 1, Iss. 1073, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

A woman enrolled in the fingolimod arm of the phase III FREEDOMS II trial developed severe haemorrhagic focal encephalitis.

By  

Reactions Weekly, Vol. 1, Iss. 1249, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

DOV Pharmaceuticals has announced that dosing has been suspended in its ongoing trial of ocinaplon due to liver enzyme elevations

By  

Reactions Weekly, Vol. 1, Iss. 1069, 2005-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Phase II trial of fenretinide in advanced renal carcinoma

By Vaishampayan Ulka   Heilbrun Lance   Parchment Ralph   Jain Vikash   Zwiebel James   Boinpally Ramesh   LoRusso Patricia   Hussain Maha  

Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. : 179-185

Springer Publishing Company

Access to resources Recommend Favorite